Lenire
Lenire is the first and only FDA-approved bimodal neuromodulation device that combines sound therapy with tongue stimulation to soothe tinnitus symptoms.

"I had a great experience with ears for you. Megan and the team were patient in helping me find the right solution for my particular hearing issue. I tried multiple devices and ended up with something that works great for my use case at the right cost for me. Would recommend to anyone needing hearing aids." Alessandra Corona
Lenire is an evidence-based treatment device designed to soothe tinnitus through a novel approach known as bimodal neuromodulation. As the first and only FDA-approved dual-mode technology for tinnitus treatment, Lenire has shown significant effectiveness in large-scale clinical trials. The device simultaneously stimulates the auditory nerves through customized sounds and the trigeminal nerve through mild electrical pulses on the tongue, working together to retrain the brain and reduce the focus on tinnitus. This non-invasive, home-based treatment solution offers new hope for individuals suffering from bothersome tinnitus who have tried other methods without success.
Proven Clinical Results
Lenire's effectiveness has been demonstrated through extensive clinical trials, making it the first device of its kind to receive FDA approval for tinnitus treatment. The TENT-A3 clinical trial, published in Nature Communications, evaluated 112 participants with an average tinnitus duration of 4.3 years and delivered compelling results:
- 88.6% of patients would recommend Lenire for tinnitus treatment
- 70.5% of participants who did not benefit from sound-alone therapy experienced clinically meaningful improvement with Lenire
- More effective than sound-alone therapy for those with moderate or worse tinnitus
- No device-related serious adverse effects reported during the trial
- 95% of participants in the TENT-A2 study reported improvement after 12 weeks of use
- 91% reported sustained relief 12 months after treatment
These findings led to Lenire receiving FDA approval in March 2023, marking it as the first and only FDA-approved bimodal tinnitus treatment device.
How Lenire Works
Lenire uses bimodal neuromodulation through three components: a Tonguetip that delivers mild electrical pulses to stimulate the trigeminal nerve, Bluetooth headphones that deliver customized sounds to stimulate the auditory nerves, and a handheld controller to manage treatment sessions.
By simultaneously stimulating these two pathways, Lenire leverages neuroplasticity—the brain's ability to adapt and learn—to retrain the brain and reduce its focus on tinnitus. Our audiologists customize the device settings to your specific tinnitus condition, and we recommend two daily 30-minute sessions for a minimum of 10 weeks to achieve optimal results.
Start Your Journey with Lenire at Ears4U
At Ears4U Hearing Services, we are a certified Lenire Tinnitus Specialty Partner dedicated to helping patients with bothersome tinnitus. Our providers spend time educating and counseling on the current understandings of tinnitus pathophysiology and develop a clear management plan to facilitate habituation. Your journey begins with an initial tinnitus assessment where we'll evaluate your suitability for Lenire and create a personalized treatment plan.
If Lenire is right for you, we'll customize your device based on your hearing profile and provide comprehensive training on its use. Your treatment includes multiple follow-up assessments to measure progress and make adjustments for maximum benefit. Contact us at 615-205-7942 or visit our Nashville or Brentwood locations to schedule your consultation and discover how Lenire can help you regain control over your tinnitus.
Take the First
Step Toward Better Hearing
Contact Nashville and Brentwood’s Leading Hearing Aid and Tinnitus Centers Today for Your Personalized Hearing Solutions!

